About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 630124, 10 pages
http://dx.doi.org/10.1155/2012/630124
Review Article

Clinical Efficacy and Safety of Buyang Huanwu Decoction for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of 19 Randomized Controlled Trials

1Department of Rehabilitation, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
2The Center of Neurology and Rehabilitation, The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou 325027, China
3School of Chinese Medicine, University of Hong Kong, Hong Kong

Received 11 June 2012; Accepted 6 September 2012

Academic Editor: Ching Liang Hsieh

Copyright © 2012 Chi-zi Hao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. L. Feigin, C. M. M. Lawes, D. A. Bennett, and C. S. Anderson, “Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century,” The Lancet Neurology, vol. 2, no. 1, pp. 43–53, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. World Health Organization, “STEPwise approach to stroke surveillance,” http://www.who.int/chp/steps/stroke/en/index.html.
  3. S. C. Johnston, S. Mendis, and C. D. Mathers, “Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling,” The Lancet Neurology, vol. 8, no. 4, pp. 345–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. D. Panagos, “The approach to optimizing stroke care,” The American Journal of Emergency Medicine, vol. 26, no. 7, pp. 808–816, 2008. View at Publisher · View at Google Scholar
  5. Z. Liu, L. Guan, Y. Wang, C. L. Xie, X. M. Lin, and G. Q. Zheng, “History and mechanism for treatment of intracerebral hemorrhage with scalp acupuncture,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 895032, 9 pages, 2012. View at Publisher · View at Google Scholar
  6. Q. R. Wang, Yilin Gaicuo, People's Medical Publishing House, Beijing, China, 2005.
  7. H. W. Wang, K. T. Liou, Y. H. Wang et al., “Deciphering the neuroprotective mechanisms of bu-yang huan-wu decoction by an integrative neurofunctional and genomic approach in ischemicstroke mice,” Journal of Ethnopharmacology, vol. 138, no. 1, pp. 22–33, 2011. View at Publisher · View at Google Scholar
  8. X. M. Li, X. C. Bai, L. N. Qin, H. Huang, Z. J. Xiao, and T. M. Gao, “Neuroprotective effects of Buyang Huanwu decoction on neuronal injury in hippocampus after transient forebrain ischemia in rats,” Neuroscience Letters, vol. 346, no. 1-2, pp. 29–32, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. S. Chen, W. C. Cheng, C. H. Yao et al., “Effects of buyang huanwu decoction on peripheral nerve regeneration using silicone rubber chambers,” American Journal of Chinese Medicine, vol. 29, no. 3-4, pp. 423–432, 2001. View at Scopus
  10. J. Sun, Y. Bi, L. Guo et al., “Buyang huanwu decoction promotes growth and differentiation of neural progenitor cells: using a serum pharmacological method,” Journal of Ethnopharmacology, vol. 113, no. 2, pp. 199–203, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Cai, B. Liu, W. Liu et al., “Buyang huanwu decoction can improve recovery of neurological function, reduce infarction volume, stimulate neural proliferation and modulate VEGF and Flk1 expressions in transient focal cerebral ischaemic rat brains,” Journal of Ethnopharmacology, vol. 113, no. 2, pp. 292–299, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. K. Zhang, X. Y. Han, and Z. Y. Che, “Effects of buyang huanwu tang combined with bone marrow mesenchymal stem cell transplantation on the expression of VEGF and Ki-67 in the brain tissue of the cerebral ischemia-reperfusion model rat,” Journal of Traditional Chinese Medicine, vol. 30, no. 4, pp. 278–282, 2010. View at Scopus
  13. H. S. Jorgensen, H. Nakayama, H. O. Raaschou, J. Vive-Larsen, M. Stoier, and T. S. Olsen, “Outcome and time course of recovery in stroke. Part II: time course of recovery. The copenhagen stroke study,” Archives of Physical Medicine and Rehabilitation, vol. 76, no. 5, pp. 406–412, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Hatano, “Experience from a multicentre stroke register: a preliminary report,” Bulletin of the World Health Organization, vol. 54, no. 5, pp. 541–553, 1976. View at Scopus
  15. The Second National Cerebrovascular Diseases Conference, “Recommendations on clinical research in stroke,” Chinese Journal of Neurology, vol. 21, pp. 57–60, 1988.
  16. The Forth National Cerebrovascular Diseases Conference, “Diagnostic criteria and disability scale for cerebrovascular diseases,” Chinese Journal of Neurology, vol. 29, article 379, 1996.
  17. The Forth National Cerebrovascular Diseases Conference, “Classification, diagnostic criteria and evaluation of neurological impairment for stroke patients,” Chinese Journal of Neurology, vol. 29, pp. 381–383, 1996.
  18. A. D. Furlan, V. Pennick, C. Bombardier, and M. van Tulder, “2009 Updated method guidelines for systematic reviews in the cochrane back review group,” Spine, vol. 34, no. 18, pp. 1929–1941, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Guyatt, A. D. Oxman, E. A. Akl et al., “GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables,” Journal of Clinical Epidemiology, vol. 64, no. 4, pp. 383–394, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. G. H. Guyatt, A. D. Oxman, R. Kunz et al., “GRADE guidelines: 2. Framing the question and deciding on important outcomes,” Journal of Clinical Epidemiology, vol. 64, no. 4, pp. 395–400, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Balshem, M. Helfand, H. J. Schünemann et al., “GRADE guidelines: 3. Rating the quality of evidence,” Journal of Clinical Epidemiology, vol. 64, no. 4, pp. 401–406, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. G. H. Guyatt, A. D. Oxman, G. Vist et al., “GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias),” Journal of Clinical Epidemiology, vol. 64, no. 4, pp. 407–415, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Y. Wu and L. F. Luo, “Influence of buyanghuanwu decoction on hs-CRP and MMP-9 of acute cerebral infarction,” Journal of Emergency in Traditional Chinese Medicine, vol. 20, no. 1, pp. 14–15, 2011 (Chinese).
  24. B. H. Zhang, “Observation of the effectiveness of buyang huanwu decoction on 40 cases of acute cerebral infarction,” Henan Traditional Chinese Medicine, vol. 4, no. 10, pp. 76–77, 2004 (Chinese).
  25. L. Guo, “The treatment of low molecular heparin calcium injection combined with buyanghuanwu decoction on 57 cases of acute cerebral infarction,” Modem Traditional Chinese Medicine, vol. 29, no. 5, pp. 3–4, 2009 (Chinese).
  26. X. Q. Jia, J. M. Liu, X. F. Wang, Z. Y. Fan, and N. Tian, “A study on effect of buyang huanwu decoctionon caspase-3 in patients with cerebral infarction,” Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care, vol. 17, no. 4, pp. 209–211, 2010 (Chinese).
  27. Y. S. Fang, X. Y. Lin, and B. S. Chen, “The eficiency and mechanism of buyanghuanwu decoction for cerebral infarction in patients with diabetes mellitus,” Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, vol. 3, no. 7, pp. 598–599, 2005 (Chinese).
  28. J. F. Zhang, Y. M. Yang, D. H. Xu, and Z. W. Liu, “A clinical analysis of treating cerebral infarction in the integrative medicine,” Clinical Journal of Chinese Medicine, vol. 1, no. 4, pp. 16–18, 2012.
  29. Y. H. Li and X. M. Hao, “Clinical observation of integrated Western medicine and buyang huanwu decoction on treating elderly cerebral infarction patients,” Chinese Joumal of Ethnomedicine and Ethnopharmacy, vol. 13, pp. 112–113, 2011 (Chinese).
  30. S. H. Kang, “Clinical observation of integrated Western medicine and flavored buyang huanwu decoction in the treatment of acute cerebral infarction,” Medicine Industry Information, vol. 3, no. 21, pp. 117–118, 2006 (Chinese).
  31. J. C. Lin, “Observation of the effectiveness of buyang huanwu decoction on acute cerebral thrombosis,” Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 17, no. 32, pp. 4994–4995, 2008 (Chinese).
  32. Y. J. Chen, “Clinical observation of buyang huanwu decoction on acute cerebral infarction,” Liaoning Journal of Traditional Chinese Medicine, vol. 34, no. 10, pp. 1413–1414, 2007 (Chinese).
  33. T. Z. Yan and X. Y. Mei, “Observation of effectiveness on treating acute cerebral infarction in the integrative medicine,” Hubei Journal of Traditional Chinese Medicine, vol. 26, no. 5, article 24, 2004 (Chinese).
  34. L. L. Cui, G. An, and H. F. Yang, “The treatment of integrative medicine on 50 cases of acute cerebral infarction,” Journal of Shanxi College of Traditional Chinese Medicine, vol. 6, no. 1, article 36, 2005 (Chinese).
  35. X. Y. Liu, “Clinical observation on treating 55 cases of acute cerebral infarction in the integrative medicine,” Hebei Journal of Traditional Chinese Medicine, vol. 32, no. 1, pp. 76–77, 2010 (Chinese).
  36. D. S. Shi and L. K. Zhang, “Clinical observation of buyang huanwu decoction on acute cerebral thrombosis,” Practical Journal of Integrated Traditional Chinese and Western Medicine, vol. 8, no. 4, pp. 228–229, 1995 (Chinese).
  37. Z. T. Run, “Observation of effectiveness of integrated Western medicine and buyang huanwu decoction on 24 cases of severe cerebral infarction,” Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care, vol. 8, no. 2, article 104, 2001 (Chinese).
  38. Y. Q. Wang and D. F. Yu, “The treatment of integrative medicine on 64 cases of cerebral infarction,” Fujian Journal of Traditional Chinese Medicine, vol. 36, no. 1, pp. 8–9, 2005 (Chinese).
  39. G. F. Lv, “The treatment integrated Western medicine and buyang huanwu decoction on 70 cases of acute Cerebral Infarction,” Clinical Journal of Traditional Chinese Medicine, vol. 21, no. 4, pp. 334–335, 2009 (Chinese).
  40. G. Y. Zheng, Z. Y. Lin, X. D. Chen, and L. X. Wei, “The Influence of buyanghuanwu decoction on the insulin and plasminogen activity in cerebral infarction patients,” Journal of Fujian College of Traditional Chinese Medicine, vol. 14, no. 6, pp. 11–13, 2004 (Chinese).
  41. Y. Q. Zhang, H. Lu, W. L. Tan, W. X. Yang, and X. F. Liao, “Influence of buyanghuanwu decoction on clinical effect and blood flow of cerebral infarction with qi-defidency and blood-stasis syndrome,” Journal of Emergency in Traditional Chinese Medicine, vol. 19, no. 8, pp. 1288–1289, 2010 (Chinese).
  42. B. Wu, M. Liu, H. Liu et al., “Meta-analysis of traditional Chinese patent medicine for ischemic stroke,” Stroke, vol. 38, no. 6, pp. 1973–1979, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Wu and M. Liu, “How to improve the quality of a clinical trial on traditional chinese medicine for stroke,” Stroke, vol. 40, no. 11, pp. e641–e642, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. K. F. Schulz, D. G. Altman, and D. Moher, “CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials,” The British Medical Journal, vol. 340, article c332, 2010. View at Publisher · View at Google Scholar · View at Scopus